{
    "body_text": [
        {
            "endOffset": 34913,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0050",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 34710,
            "title": "Periodic review"
        },
        {
            "endOffset": 13474,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "However, large-scale international prospective studies of healthy pregnancies show little difference in growth curves between populations [22].",
            "startOffset": 13331,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 14099,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Some authors have reported neonatal outcomes including identification of low birth weight (LBW) and SGA infants without an attempt to detect these events in pregnancy [29\u201331].",
            "startOffset": 13924,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 38553,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "The guidelines are not intended to guide the primary reporting of FGR to a surveillance system or study monitor.",
            "startOffset": 38441,
            "title": "Data collection"
        },
        {
            "endOffset": 17434,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search resulted in the identification of 23,441 English-language references, 5480 of which were published within the past five years.",
            "startOffset": 17297,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 46314,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 46186,
            "title": "Data analysis"
        },
        {
            "endOffset": 42243,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 42092,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 20282,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "The case definition has been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 20172,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 13148,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Though these measurements yielded reliable estimations of fetal weight, the growth curves lacked generalizability, particularly in an international context [18].",
            "startOffset": 12987,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 12986,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The sentinel investigations into FGR used measurements of the fetal head, abdomen, and femur to develop growth curves within small homogenous patient populations [17].",
            "startOffset": 12819,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 20171,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "The number of sonographic findings that will be documented for each case may vary considerably depending on availability of technology in a given setting and availability of additional clinical information, such as pregnancy dating, critical to establishing a diagnosis.",
            "startOffset": 19901,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 20881,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Level B may be more sensitive for FGR but includes less specific findings with less certainty for its pathology.",
            "startOffset": 20769,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 21163,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "It needs to be emphasized that the grading of definition levels is entirely about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 21025,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 35147,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 1\u2217 evidence of pregnancy dating [67].",
            "startOffset": 35104,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 11257,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Therefore, antenatal recognition and monitoring of fetal growth restriction (FGR) is an important component of prenatal care [6\u20138].",
            "startOffset": 11126,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 15264,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As maternal vaccination becomes an increasingly prioritized component of routine prenatal care, monitoring for adverse vaccine-related outcomes gains similar importance.",
            "startOffset": 15095,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 28517,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "An umbilical artery PI above the 95%ile has been associated with adverse perinatal outcomes similar to absent or reversed diastolic frequencies but with lower incidence [24].",
            "startOffset": 28343,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 43436,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Date/time of onset,4 first observation5 and diagnosis,6 end of episode7 and final outcome.8",
            "startOffset": 42631,
            "title": "The adverse event"
        },
        {
            "endOffset": 37280,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "It is, however, a useful sonographic findings in situations lacking access to Doppler ultrasound and often impacts clinical management of pregnancies with suspected FGR despite its lack of specificity.",
            "startOffset": 37079,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 36332,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 10% using locally-accepted growth curve with no findings of oligohydramnios\u2020 with inability to assess umbilical artery Doppler.",
            "startOffset": 36176,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 15691,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Timely diagnosis of a pathologic disorder of growth potential in utero, as opposed to relying solely on a postnatal diagnosis of a pathologically small infant, is necessary to identify a temporal relationship between the diagnosis of FGR and a vaccine of interest.",
            "startOffset": 15427,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 50041,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on FGR following immunization to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 49785,
            "title": "Data presentation"
        },
        {
            "endOffset": 31207,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Though an estimated fetal weight below the tenth percentile in association with oligohydramnios does not predict adverse outcomes, it does suggest pathologic FGR more so than an isolated finding of a small fetus.",
            "startOffset": 30995,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 30633,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Assessment of amniotic fluid volume is a routine component of prenatal ultrasound and diagnosis with varying definitions of oligohydramnios in the literature.",
            "startOffset": 30475,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 48820,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 48720,
            "title": "Data analysis"
        },
        {
            "endOffset": 26917,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "As with the acquisition of measurements, adherence to existing performance standards should be ensured when performing this adjunctive testing [62].",
            "startOffset": 26769,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 18087,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "No immuzation-related studies contained definitions of FGR and this outcome was seldom discussed.",
            "startOffset": 17990,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 28342,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The PI is calculated using the peak systolic velocity, end diastolic velocity, and time averaged velocity in a given artery and comparing this value to existing standards for a given gestational age.",
            "startOffset": 28143,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35630,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 2 of diagnostic certainty",
            "startOffset": 35599,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 31661,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Serial ultrasound would improve sensitivity for FGR through identification of fetuses failing to reach their growth potential but not falling below the tenth percentile.",
            "startOffset": 31492,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36642,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "Level 1 pregnancy dating depends on a confirmatory ultrasound performed \u2a7d13 6/7 weeks gestation [67].",
            "startOffset": 36541,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 20548,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, an additional diagnostic level has been included in the definition, offering a stepwise increase of sensitivity from Level 1 to Level 2, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 20283,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 39675,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 39569,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 33756,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "In cases where FGR can be identified prior to vaccine administration exclusion of these pregnancies from the trial can be considered.",
            "startOffset": 33623,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 29623,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Aside from an abnormal CPR, this subset of FGR is suggested by an abdominal circumference lagging the estimated weight of the fetus [24].",
            "startOffset": 29486,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 46182,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on FGR to allow for comparability of data, and are recommended as an addition to data analyzed for the specific study question and setting.",
            "startOffset": 45966,
            "title": "Data analysis"
        },
        {
            "endOffset": 35065,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Fetal growth restriction is a sonographic finding characterized by:",
            "startOffset": 34998,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 15847,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is a paucity of data on FGR in existing vaccine trials, perhaps in part due to the controversy surrounding the diagnosis within the medical community.",
            "startOffset": 15691,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 46457,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 46315,
            "title": "Data analysis"
        },
        {
            "endOffset": 37078,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "When compared to umbilical artery Dopplers, oligohydramnios lacks specificity for pathologic placental underperfusion and lacks association with adverse perinatal outcomes [24].",
            "startOffset": 36901,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 51966,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Any publication of data on FGR should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 51832,
            "title": "Data presentation"
        },
        {
            "endOffset": 14979,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This relationship between maternal infection and FGR is well described for many diseases\u2014even in the absence of congenital infection [39\u201344].",
            "startOffset": 14838,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 27470,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Absence or reversal of diastolic velocities in the umbilical artery has been associated with adverse perinatal outcomes that are rare in the setting of normal umbilical artery velocities [63].",
            "startOffset": 27278,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 49440,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "When only a small number of cases are presented, the respective values or time course can be presented individually.",
            "startOffset": 49324,
            "title": "Data analysis"
        },
        {
            "endOffset": 47911,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Not a case of FGR",
            "startOffset": 47894,
            "title": "Data analysis"
        },
        {
            "endOffset": 15426,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The complex interplay between FGR, infection, and medical comorbidity makes early detection and diagnosis of this pregnancy complication of paramount importance.",
            "startOffset": 15265,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 52729,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Whether the day of immunization was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 52642,
            "title": "Data presentation"
        },
        {
            "endOffset": 20664,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Each Level has been further subdivided into subcategories of A and B in an attempt to better define pathologic FGR.",
            "startOffset": 20549,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 21511,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Detailed information about the severity of the event should additionally always be recorded, as specified by the data collection guidelines.",
            "startOffset": 21371,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 39963,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Name and contact information of person reporting3 and/or diagnosing the FGR as specified by country-specific data protection law.",
            "startOffset": 39696,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 21770,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Magnetic resonance imaging (MRI) of the fetus and placenta shows potential for furthering understanding of pathophysiology.",
            "startOffset": 21647,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 38746,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 38554,
            "title": "Data collection"
        },
        {
            "endOffset": 23352,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In settings where ultrasound is unavailable for an antenatal diagnosis of disorders of fetal growth, investigators may use the Brighton Definition for Small for Gestational Age neonates as an alternative [48].",
            "startOffset": 23143,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 14838,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In contrast FGR in lower income countries is more likely to be associated with malnutrition or parasitic diseases, with malaria being the classic example [34\u201338].",
            "startOffset": 14676,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 18237,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The most commonly encountered definitions were in medical society statements and contained substantial variation in both terminology and definitions.",
            "startOffset": 18088,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 40058,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 39966,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 49765,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Data on FGR obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates of FGR in non-exposed populations, and should be analyzed by study arm and dose where possible, e.g. in prospective clinical trials [47].",
            "startOffset": 49444,
            "title": "Data analysis"
        },
        {
            "endOffset": 16991,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 16722,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 48334,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Subjects with Fetal Growth Restriction by Interval to Presentation",
            "startOffset": 48268,
            "title": "Data analysis"
        },
        {
            "endOffset": 28142,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Contemporary expert consensus guidelines attempting to better characterize early-onset and late-onset FGR underscore the clinical utility of measurements such as the CPR and the umbilical artery pulsatility index (PI) in assessment of FGR [60].",
            "startOffset": 27898,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 19011,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "The term SGA has been proposed by some groups, including the Brighton Collaborative, as a diagnosis limited to neonates [11,48].",
            "startOffset": 18883,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 47471,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Level 1: Criteria as specified in the Fetal Growth Restriction case definition",
            "startOffset": 47393,
            "title": "Data analysis"
        },
        {
            "endOffset": 23142,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Ultrasound may not be universally available in all clinical settings, but its presence is requisite for diagnosis of FGR as an adverse event within the context of vaccine trials.",
            "startOffset": 22964,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 40314,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0090",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 40208,
            "title": "Demographics"
        },
        {
            "endOffset": 52105,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The method, frequency and duration of monitoring for FGR;",
            "startOffset": 52048,
            "title": "Data presentation"
        },
        {
            "endOffset": 52537,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 52495,
            "title": "Data presentation"
        },
        {
            "endOffset": 27897,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Doppler studies of the middle cerebral artery (MCA), ductus venosus, uterine arteries and the relationships between these values (e.g. the cerebral placental ratio (CPR)) have also been employed in the clinical description and prediction of FGR.",
            "startOffset": 27652,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 40478,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0090",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 40317,
            "title": "Demographics"
        },
        {
            "endOffset": 22605,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "This adjunct testing offers clinical utility for screening for and further understanding of FGR but lends little to establishing the initial diagnosis.",
            "startOffset": 22454,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 39534,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of FGR following immunization.",
            "startOffset": 39353,
            "title": "Data collection"
        },
        {
            "endOffset": 47891,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Reported FGR with insufficient evidence to meet the case definition11",
            "startOffset": 47624,
            "title": "Data analysis"
        },
        {
            "endOffset": 19400,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "In order to distinguish between a neonatal and fetal diagnosis of disorders of growth, use of the term SGA to reference a fetal disorder of growth will be avoided.",
            "startOffset": 19237,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 26471,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Selected growth curves should be internationally validated using a large sample size and published as a peer-reviewed study with an available reference.",
            "startOffset": 26319,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 44130,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Values and units of routinely measured parameters (e.g. measurements, amniotic fluid volume, umbilical artery Doppler studies, additional Doppler studies) \u2013 in particular those indicating the severity of the event;",
            "startOffset": 43916,
            "title": "The adverse event"
        },
        {
            "endOffset": 52447,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 52346,
            "title": "Data presentation"
        },
        {
            "endOffset": 11125,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Fetuses that fail to meet their growth potential in utero are at risk for adverse antenatal and postnatal events such as stillbirth, preterm birth, and adverse neonatal and long-term health outcomes [1\u20135].",
            "startOffset": 10920,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 41731,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Date and time of immunization(s).",
            "startOffset": 41698,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 40704,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0095",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 40598,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 13923,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The majority of the prior vaccine studies in pregnant women, including specifically those focused on obstetric outcomes, do not address FGR as an adverse outcome [25\u201328].",
            "startOffset": 13753,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 25649,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The majority of existing society guidelines either lack recommendations on specific growth curve use or suggest employing a customized curve [12,14,49].",
            "startOffset": 25497,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 51128,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 51022,
            "title": "Data presentation"
        },
        {
            "endOffset": 30475,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Based on this information and the absence of recommendation for routine use in existing clinical guidelines use of Doppler other than velocimetry in the umbilical artery are not included in the case definition for FGR [23,24].",
            "startOffset": 30249,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 47552,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Level 2: Criteria as specified in the Fetal Growth Restriction case definition",
            "startOffset": 47474,
            "title": "Data analysis"
        },
        {
            "endOffset": 22087,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "At the other end of the spectrum, exam findings such as symphysis fundal height measurements are clinically ubiquitous for the detection of FGR [50].",
            "startOffset": 21938,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 42627,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Sonographic findings of FGR and if there was medical confirmation of the event (i.e. patient seen or images reviewed by physician).",
            "startOffset": 42496,
            "title": "The adverse event"
        },
        {
            "endOffset": 11901,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "FGR can be a consequence of maternal, fetal, or placental factors.",
            "startOffset": 11835,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 35096,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 1 of diagnostic certainty",
            "startOffset": 35065,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 51519,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 51292,
            "title": "Data presentation"
        },
        {
            "endOffset": 51291,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Although immunization safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 51128,
            "title": "Data presentation"
        },
        {
            "endOffset": 51633,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 51523,
            "title": "Data presentation"
        },
        {
            "endOffset": 35750,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 3% using locally-accepted growth curve",
            "startOffset": 35683,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 35886,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Absent or reversed end-diastolic flow of the umbilical artery Doppler.",
            "startOffset": 35816,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 35598,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Lack of absent or reversed end-diastolic flow of the umbilical artery or oligohydramnios.",
            "startOffset": 35509,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 22766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Therefore, the Brighton case definition of FGR will focus on use of a combination of B-mode and Doppler ultrasound technology to establish the diagnosis of FGR.",
            "startOffset": 22606,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36173,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 1\u2217 evidence of pregnancy dating [67].",
            "startOffset": 36130,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40558,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0090",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 40512,
            "title": "Demographics"
        },
        {
            "endOffset": 13649,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Additional studies investigating the utility of adjunct studies such as amniotic fluid assessment and use of Doppler attempt to further clarify the definition of FGR [23,24].",
            "startOffset": 13475,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 35289,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 10% using locally-accepted growth curve.",
            "startOffset": 35220,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 11572,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Furthermore, terminology such as intrauterine growth restriction (IUGR) or small for gestational age (SGA) are used interchangeably and without specificity to describe this clinical entity.",
            "startOffset": 11383,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 11717,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In its simplest form, FGR is defined as a sonographic estimation of fetal weight below the tenth percentile for a given gestational age [11\u201314].",
            "startOffset": 11573,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 24743,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "As previously described, the choice of a specific growth curve and its associated characteristics is a subject of ongoing debate in the obstetric community based on wide variation between published reference curves [18].",
            "startOffset": 24523,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 29319,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The CPR is derived by comparing the PI in the umbilical artery to that in the MCA and has a similar role in predicting adverse outcomes likely due to its role in detecting brain-sparing growth restriction [64,65].",
            "startOffset": 29106,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35362,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Absent or reversed end-diastolic flow of the umbilical artery Doppler.",
            "startOffset": 35292,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 29808,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "An isolated abdominal circumference below the tenth percentile can be associated with adverse outcomes and has been utilized in recent consensus guidelines to define pathology [24,60].",
            "startOffset": 29624,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 52641,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The validated instrument of data collection (e.g. standardized questionnaire, diary card, report form);",
            "startOffset": 52538,
            "title": "Data presentation"
        },
        {
            "endOffset": 14675,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "FGR associated with maternal comorbidity such as advanced maternal age or gastric bypass surgery can be considered unique to countries with higher healthcare related expenditures [32,33].",
            "startOffset": 14488,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 44506,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Outcome8 at last observation.",
            "startOffset": 44477,
            "title": "The adverse event"
        },
        {
            "endOffset": 17641,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "All abstracts were screened for relevance to a contemporary definition of FGR in a singleton pregnancy with particular attention to those related to infection, immunization, and under-represented countries.",
            "startOffset": 17435,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 21646,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "FGR is most often diagnosed by use of ultrasound.",
            "startOffset": 21597,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 13330,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Contemporary studies on FGR have advocated individualized growth curves accounting for maternal and fetal characteristics such as ethnicity and gender to solve this dilemma [19\u201321].",
            "startOffset": 13149,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 22963,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "This approach should allow for adequate sensitivity and specificity without making identification of the adverse event overly cumbersome for investigators in study settings with limited resources.",
            "startOffset": 22767,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 47390,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Event meets case definition",
            "startOffset": 47363,
            "title": "Data analysis"
        },
        {
            "endOffset": 50627,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "All reported events of FGR should be presented according to the categories listed in guideline 30.",
            "startOffset": 50529,
            "title": "Data presentation"
        },
        {
            "endOffset": 24879,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Many publically available growth curves currently available in ultrasound machines were derived from small homogenous populations [17].",
            "startOffset": 24744,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 32760,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Specific time frames for onset of symptoms following immunization are not included in the definition of FGR.",
            "startOffset": 32652,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 33260,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunization to onset of FGR should not be an integral part of such a definition.",
            "startOffset": 33110,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 32913,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "There is a paucity of data about relationship between immunization and FGR with no evidence on which to base recommendations on a temporal relationship.",
            "startOffset": 32761,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 35599,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "\u2020",
            "startOffset": 35598,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 49124,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 49019,
            "title": "Data analysis"
        },
        {
            "endOffset": 53501,
            "parents": [],
            "secId": "s0125",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 53345,
            "title": "Disclaimer"
        },
        {
            "endOffset": 24523,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Selected sonographic studies should follow international published standards for obtaining and reporting measurements with appropriate references to resources used during scientific publication.",
            "startOffset": 24329,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 19236,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Other society guidelines suggest using IUGR to identify those fetuses at risk of pathologic growth restriction and limiting the use of SGA to reference a constitutionally small fetus without evidence of pathology [12\u201314,49].",
            "startOffset": 19012,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 47587,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Event does not meet case definition",
            "startOffset": 47552,
            "title": "Data analysis"
        },
        {
            "endOffset": 33390,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Instead, where feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 33261,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 41936,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.), diluent name, and number of dose if part of a series of immunizations against the same disease).",
            "startOffset": 41735,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 23719,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "A variety of fetal biometric measurements and functional Doppler studies have been studied to optimize the detection of FGR.",
            "startOffset": 23595,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 32390,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Access to basic B-mode ultrasound is requisite for the diagnosis at any level of certainty, with a requirement for basic Doppler capabilities for the highest level of diagnostic certainty.",
            "startOffset": 32202,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35680,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 2 evidence of pregnancy dating [67].",
            "startOffset": 35638,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 15992,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Given the clinical variation in the definition, the absence of a uniformly accepted definition of FGR following immunizations is not surprising.",
            "startOffset": 15848,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 25117,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Customized growth curves incorporating maternal and fetal characteristics have shown improved specificity over population-based curves in individual studies yet fail to demonstrate superiority in the most recent meta-analyses [19,21,56].",
            "startOffset": 24880,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36426,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "Absence of ultrasound for use in assessment of estimated fetal weight.",
            "startOffset": 36356,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 30248,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Though assessment for brain-sparing using these techniques would add specificity to the pathologic FGR diagnosis, it would involve significant additional technical requirements as well as increase the risk of false positives due to technical error.",
            "startOffset": 30000,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36028,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 10%ile using locally-accepted growth curve",
            "startOffset": 35957,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 23981,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Biometric parameters typically involve an assessment of head size (e.g. biparietal diameter (BPD), head circumference (HC), occipitofrontal diameter (OFD)), abdominal size (e.g. abdominal circumference (AC) or abdominal diameter (AD)), and femur length [54,55].",
            "startOffset": 23720,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 28940,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The working group balanced specificity for FGR with establishing a case definition that can be achieved across a wide range of clinical settings with varying access to equipment and operator training.",
            "startOffset": 28740,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 33926,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Given the increase in adverse events in pregnancies affected by FGR this strategy may avoid an overestimation of associations between the vaccine and an adverse outcome.",
            "startOffset": 33757,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 51994,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "It is essential to specify:",
            "startOffset": 51967,
            "title": "Data presentation"
        },
        {
            "endOffset": 49018,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 48824,
            "title": "Data analysis"
        },
        {
            "endOffset": 36128,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "No findings of absent or reversed end-diastolic flow of the umbilical artery or oligohydramnios\u2020.",
            "startOffset": 36031,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 47621,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Additional categories for analysis",
            "startOffset": 47587,
            "title": "Data analysis"
        },
        {
            "endOffset": 17989,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The literature search revealed extensive literature on the definition of FGR and development of associated growth curves and adjunct testing.",
            "startOffset": 17848,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 41556,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0095",
            "sentence": "Immunization history (i.e. previous immunizations and any adverse event following immunization (AEFI)), in particular occurrence of FGR after a previous immunization.",
            "startOffset": 41390,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 43892,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Concurrent signs, symptoms, and diseases.9",
            "startOffset": 43440,
            "title": "The adverse event"
        },
        {
            "endOffset": 52345,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 52282,
            "title": "Data presentation"
        },
        {
            "endOffset": 12065,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Diagnosing all fetuses with an estimated fetal weight (EFW) below the tenth percentile with FGR fails to account for the individual growth potential of each fetus.",
            "startOffset": 11902,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 21370,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level Two rather than Level One if it could reasonably be of non-FGR etiology (e.g. in cases of limited evidence of pregnancy dating).",
            "startOffset": 21164,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 33479,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "Further, FGR often occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 33390,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 11835,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Though this definition is simple to understand and translating into practice, it is an inadequate definition for FGR.",
            "startOffset": 11718,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 52494,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 52448,
            "title": "Data presentation"
        },
        {
            "endOffset": 31381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Therefore, in an attempt to improve the sensitivity of the case definition for FGR oligohydramnios has been included in the definition realizing it may decrease specificity.",
            "startOffset": 31208,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 53641,
            "parents": [],
            "secId": "s0125",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organization (e.g., government, university, or corporation).",
            "startOffset": 53502,
            "title": "Disclaimer"
        },
        {
            "endOffset": 35218,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 3% using locally-accepted growth curve.",
            "startOffset": 35150,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 12818,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Numerous studies have attempted to improve the sensitivity and specificity of the definition through adjunct testing and optimization of growth curves used to define the tenth percentile diagnostic cutoff.",
            "startOffset": 12613,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 34073,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "In some settings it may be impossible to screen for FGR or obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 33927,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 37596,
            "parents": [],
            "secId": "s0070",
            "sentence": "It was the consensus of the Brighton Collaboration Fetal Growth Restriction Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about FGR.",
            "startOffset": 37366,
            "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
        },
        {
            "endOffset": 26051,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Furthermore, prescribing a specific standard may unduly restrict participation of study sites with limited resources to access additional growth curves.",
            "startOffset": 25899,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 26768,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In addition to a sonographic estimation of fetal weight, additional techniques can be used to aid in the diagnosis of FGR.",
            "startOffset": 26646,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 42088,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "The anatomical sites (including left or right side) of all immunizations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 41940,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 48268,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "If few cases are reported, the concrete time course could be analyzed for each; for a large number of cases, data can be analyzed in the following increments:",
            "startOffset": 48110,
            "title": "Data analysis"
        },
        {
            "endOffset": 34641,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0045",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 34507,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 23594,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The most basic definition of FGR includes a fetus with a sonographic estimation of fetal weight below the tenth percentile for a given gestational age with increasing specificity for adverse perinatal outcomes below the third percentile [24].",
            "startOffset": 23352,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 37924,
            "parents": [],
            "secId": "s0070",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of FGR.",
            "startOffset": 37678,
            "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
        },
        {
            "endOffset": 48719,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "The duration of a possible FGR could be analyzed as the interval between the date/time of onset3 of the first sonographic findings consistent with the definition and the end of diagnosis7 and/or final outcome.8",
            "startOffset": 48509,
            "title": "Data analysis"
        },
        {
            "endOffset": 12613,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "An ideal definition of FGR would detect those fetuses with a pathologic failure to meet their growth potential subsequently at risk of adverse outcomes.",
            "startOffset": 12461,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 25496,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Yet translation of these growth standards into clinical practice is ongoing with presumably limited access to this data in existing technology [59].",
            "startOffset": 25348,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 29485,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Brain-sparing growth restriction in which a fetus redirects blood flow away from the viscera in favor of the brain is associated with poorer perinatal outcomes [66].",
            "startOffset": 29320,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36900,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "\u2020Oligohydramnios is defined as a decreased amniotic fluid volume as defined by amniotic fluid index less than 8 cm or deepest vertical pocket less than 2 cm in the presence of intact membranes without concern for fetal anomalies contributing to its etiology.",
            "startOffset": 36642,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 41076,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0095",
            "sentence": "Past medical history, including hospitalizations, underlying diseases/disorders with careful identification as to their presence in the mother or fetus, pre-immunization signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 40707,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 41320,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0095",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunization including prescription and non-prescription medication as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 41079,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 41386,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0095",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 41321,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 33109,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing causal relationships requires ascertainment of the outcome (e.g. FGR) independent from the exposure (e.g. immunizations).",
            "startOffset": 32914,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 18562,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "An inventory comprising the 102 relevant articles along with society definitions of FGR was made available to working group members via the Collections feature of MyNCBI.",
            "startOffset": 18392,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 33622,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "When possible, a sonographic assessment of fetal weight before vaccination could aid in the evaluation of FGR prior to vaccine administration.",
            "startOffset": 33480,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 53800,
            "parents": [],
            "secId": "s0125",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 53642,
            "title": "Disclaimer"
        },
        {
            "endOffset": 12230,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Constitutionally small fetuses who might be expected to have a lower birthweight based on parental characteristics may be misdiagnosed as pathologically small [15].",
            "startOffset": 12066,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 51018,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Terms to describe FGR such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d \u201csignificant\u201d, \u201cearly onset\u201d, \u201clate onset\u201d, \u201casymmetric\u201d, \u201csymmetric\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 50769,
            "title": "Data presentation"
        },
        {
            "endOffset": 30994,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In the absence of evidence of rupture of membranes or fetal anomalies contributing to the pathology, oligohydramnios is often interpreted as a marker for placental insufficiency and therefore pathology.",
            "startOffset": 30792,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 37677,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 37597,
            "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
        },
        {
            "endOffset": 22268,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "This clinical measurement lacks sensitivity, offers little insight into potential for pathology, and lacks evidence for routine use limiting its utility in a research setting [51].",
            "startOffset": 22088,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 34237,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0040",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting requirements for FGR screening and arbitrary time frames.",
            "startOffset": 34074,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 18882,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "Terms such as intrauterine growth restriction (IUGR) and small for gestational age (SGA) are often used in clinical practice interchangeably with FGR.",
            "startOffset": 18732,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 34692,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0045",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 34642,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 51828,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 51763,
            "title": "Data presentation"
        },
        {
            "endOffset": 13752,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Despite these controversies in defining FGR, its detection is an important component of antenatal care.",
            "startOffset": 13649,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 49323,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Increments specified above should be used.",
            "startOffset": 49281,
            "title": "Data analysis"
        },
        {
            "endOffset": 34506,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0045",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines which are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 34297,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 38440,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following immunization to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 38193,
            "title": "Data collection"
        },
        {
            "endOffset": 14299,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Though neonatal disorders of growth potential could be considered a postnatal diagnosis of FGR, they are different diagnoses with distinct implications within the context of studies on immunizations.",
            "startOffset": 14100,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 41694,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 41588,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 29105,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Similar reasoning guided the exclusion of CPR in the group\u2019s definition of FGR.",
            "startOffset": 29026,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 27096,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "These additional studies can include an assessment of amniotic fluid volume and Doppler velocities through varying maternal, placental, and fetal vessels where technology allows.",
            "startOffset": 26918,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 12460,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Conversely, fetuses destined for a higher birthweight may fail to reach their growth potential due to a pathologic process yet never fall below a threshold based on fetal or birth weight below a specific centile (e.g. 10th) [16].",
            "startOffset": 12231,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 21937,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "However, this technology is time-consuming, expensive, and primarily restricted to research settings limiting its use for inclusion in the Brighton definition of FGR.",
            "startOffset": 21771,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 44323,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Results of laboratory examinations, surgical and/or pathological findings and diagnoses if present.",
            "startOffset": 44224,
            "title": "The adverse event"
        },
        {
            "endOffset": 44473,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Follow up given for FGR, especially follow up monitoring (e.g. repeat ultrasounds or other assessments of fetal well-being) and delivery planning.",
            "startOffset": 44327,
            "title": "The adverse event"
        },
        {
            "endOffset": 15094,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Specifically, FGR has been described as a consequence of vaccine-preventable illnesses, such as influenza [45,46].",
            "startOffset": 14980,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 16721,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described in the overview paper as well as on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Fetal Growth Restriction Working Group was formed in 2015 and included members from clinical, academic, public health, and industry backgrounds [47].",
            "startOffset": 16373,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 25347,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Contemporary population-based growth curves derived from a diverse population of low-risk pregnancies such as those from the INTERGROWTH-21st package show little variation in fetal size across non-isolated populations [22,57,58].",
            "startOffset": 25118,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 16184,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This is, however, a missed opportunity, as data comparability across trials or surveillance systems would facilitate data interpretation and promote the scientific understanding of the event.",
            "startOffset": 15993,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 20768,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "Within both Levels, a subgroup of A provides better specificity and certainty for a pathologic process.",
            "startOffset": 20665,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 35813,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal below 10% using locally-accepted growth curve",
            "startOffset": 35752,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 51762,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 51637,
            "title": "Data presentation"
        },
        {
            "endOffset": 52281,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 52106,
            "title": "Data presentation"
        },
        {
            "endOffset": 28739,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "This clinically useful measurement would likely improve the specificity of pathologic growth restriction, but has a slightly greater technical requirement with a need for further interpretation using a normative standard.",
            "startOffset": 28518,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 29999,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Reference standards for this individual measurement have similar variation and challenges to those involving estimated fetal weight and rely on a single measurement to define pathology [18].",
            "startOffset": 29809,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 48109,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "The interval between immunization and reported FGR could be defined as the date/time of immunization to the date/time of onset4 of the first symptoms and/or signs consistent with the definition.",
            "startOffset": 47915,
            "title": "Data analysis"
        },
        {
            "endOffset": 53075,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Whether the date of onset4 and/or the date of first observation5 and/or the date of diagnosis6 was used for analysis; and12",
            "startOffset": 52730,
            "title": "Data presentation"
        },
        {
            "endOffset": 44223,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Method of measurement (e.g. type of ultrasound, particular growth curve or references used);",
            "startOffset": 44131,
            "title": "The adverse event"
        },
        {
            "endOffset": 42271,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0100",
            "sentence": "Needle length and gauge.",
            "startOffset": 42247,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 50765,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Data on possible FGR events should be presented in accordance with data collection guidelines 1\u201323 and data analysis guidelines 30\u201335.",
            "startOffset": 50631,
            "title": "Data presentation"
        },
        {
            "endOffset": 32623,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In an attempt to make a Level One diagnosis of FGR accessible, after thoughtful consideration more complex criteria that could improve the sensitivity or specificity of detection of disorders of fetal growth potential were excluded.",
            "startOffset": 32391,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 44664,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0105",
            "sentence": "Exposures other than the immunization 24 h before and after immunization (e.g. food, environmental) considered potentially relevant to the reported event.",
            "startOffset": 44510,
            "title": "The adverse event"
        },
        {
            "endOffset": 32201,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "However great care was taken to consider the feasibility of the definition within the context of a vaccine trial with the potential for study sites with varying access to healthcare resources and technology.",
            "startOffset": 31994,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 46565,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 46458,
            "title": "Data analysis"
        },
        {
            "endOffset": 22453,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Additional studies such as placental pathologic examination, placental biomarkers, and related clinical diagnoses may offer insight into the underlying pathophysiology for FGR [52,53].",
            "startOffset": 22269,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 31815,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The improvement in sensitivity would come at a tradeoff for additional ultrasound scans which may be overly cumbersome in the context of a vaccine trial.",
            "startOffset": 31662,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 47363,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "Event classification in 4 categories10",
            "startOffset": 46565,
            "title": "Data analysis"
        },
        {
            "endOffset": 39159,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "Guidelines 1\u201342 below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [68,69].",
            "startOffset": 38746,
            "title": "Data collection"
        },
        {
            "endOffset": 25898,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Resolving the ongoing debate of the ideal growth curve selection is beyond the scope of this project.",
            "startOffset": 25797,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 29026,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "For this reason, pulsatility indices were not included in the case definition of FGR.",
            "startOffset": 28941,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 21025,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0030",
            "sentence": "In this way it is hoped that all possible cases of FGR can be captured with clarity as to the concern for a disorder of fetal growth potential.",
            "startOffset": 20882,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 25797,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "However, all of these guidelines were developed before the recent publication of newer fetal growth standards and expert opinion varies [10,60,61].",
            "startOffset": 25650,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 52047,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "The method of pregnancy dating;",
            "startOffset": 52016,
            "title": "Data presentation"
        },
        {
            "endOffset": 24328,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Healthcare providers performing obstetric ultrasound should be trained in proper technique with assessment of quality to ensure inter- and intra-rater reliability.",
            "startOffset": 24165,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 26208,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Though the Brighton definition of FGR does not include a single specific growth curve, several key features of a selected growth curve should be emphasized.",
            "startOffset": 26052,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 53335,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Use of this case definition for FGR, in the abstract or methods section of a publication.13",
            "startOffset": 53076,
            "title": "Data presentation"
        },
        {
            "endOffset": 19549,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "IUGR and FGR are used interchangeably with less confusion as both clearly reference a diagnosis of growth restriction established prior to delivery.",
            "startOffset": 19401,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 31993,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "The current case definition balances sensitivity and specificity of the definition of FGR.",
            "startOffset": 31903,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 14376,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The likely cause of pathologic FGR can vary in according to clinical setting.",
            "startOffset": 14299,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 24164,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "A comprehensive guide to the technical performance of these measurements and other sonographic technique is beyond the scope of this paper, but several key points must be emphasized.",
            "startOffset": 23982,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35432,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 1\u2217 evidence of pregnancy dating [67].",
            "startOffset": 35389,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40168,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Relation to the patient (e.g., immunizer [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 40061,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 40509,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                },
                {
                    "id": "s0075",
                    "title": "Data collection"
                },
                {
                    "id": "s0085",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0090",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 40481,
            "title": "Demographics"
        },
        {
            "endOffset": 49280,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0115",
            "sentence": "The distribution of data (as numerator and denominator data) could be analyzed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 49128,
            "title": "Data analysis"
        },
        {
            "endOffset": 19791,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0025",
            "sentence": "To limit confusion between these variably defined terms the Brighton definitions will utilize the term fetal growth restriction to define this adverse advent with levels of diagnostic certainty to further describe concern for pathologic FGR.",
            "startOffset": 19550,
            "title": "The term fetal growth restriction"
        },
        {
            "endOffset": 26646,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "An optimal curve would be based on pregnancies with reliable early pregnancy dating, prospective data collection, and validation of measurements to avoid intra-observer bias.",
            "startOffset": 26472,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 17847,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "102 articles with potentially relevant material were reviewed in more detail, in order to identify studies using case definitions or, in their absence, providing clinical descriptions of the case material.",
            "startOffset": 17642,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 27277,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Amongst the variety of Doppler studies available, assessment of velocities in the umbilical artery is one of the most accessible both in terms of technical ease and interpretation.",
            "startOffset": 27097,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 17296,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search was performed using Medline, Embase and the Cochrane Libraries, including the terms [fetal (Fetal) growth restriction or retardation], [intrauterine growth restriction or retardation] and [small for gestational age].",
            "startOffset": 16991,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 18391,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Similar heterogeneity was found in the definition of FGR throughout scientific studies addressing outcomes and management of this pregnancy complication.",
            "startOffset": 18238,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse events following immunization"
        },
        {
            "endOffset": 31903,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "In the interest of feasibility these criteria were not included in the case definition.",
            "startOffset": 31816,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 14487,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Some etiologies of FGR, such as preeclampsia or congenital anomalies, may be similar across clinical settings.",
            "startOffset": 14377,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 26318,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Study sites in any given trial should select a single curve to allow for meaningful comparison between sites.",
            "startOffset": 26209,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35506,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Estimated fetal weight below 10%ile using locally-accepted growth curve",
            "startOffset": 35435,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 30791,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Potential etiologies for oligohydramnios are diverse and this finding is less specific than Doppler velocities in predicting adverse perinatal outcomes [24].",
            "startOffset": 30634,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 36540,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0065",
            "sentence": "*Level 1 evidence of pregnancy dating as defined by the Preterm Birth Working Group of the Brighton Collaboration.",
            "startOffset": 36426,
            "title": "Insufficient evidence"
        },
        {
            "endOffset": 11382,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Despite the clinical and public health importance of this problem there is no universally accepted definition of FGR [9\u201310].",
            "startOffset": 11258,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for fetal growth restriction as an adverse event following immunization"
        },
        {
            "endOffset": 38175,
            "parents": [],
            "secId": "s0070",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 37925,
            "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
        },
        {
            "endOffset": 27652,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Inclusion of umbilical artery Doppler waveforms in the definition allows for added certainty in the diagnosis of pathologic growth restriction with minimal additional time or skill.",
            "startOffset": 27471,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 31491,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                },
                {
                    "id": "s0020",
                    "title": "Rationale for selected decisions about the case definition of fetal growth restriction as an adverse event following immunization"
                }
            ],
            "secId": "s0035",
            "sentence": "Additional sensitivity in the definition could be achieved by tracking an individual fetus\u2019s growth over time.",
            "startOffset": 31381,
            "title": "Rationale for individual criteria or decision made related to the case definition"
        },
        {
            "endOffset": 35954,
            "parents": [
                {
                    "id": "s0055",
                    "title": "Case definition of fetal growth restriction"
                }
            ],
            "secId": "s0060",
            "sentence": "Level 2 evidence of pregnancy dating [67].",
            "startOffset": 35912,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 39352,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0075",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunizations, and a detailed description of the adverse event, in this case, of FGR following immunization.",
            "startOffset": 39160,
            "title": "Data collection"
        },
        {
            "endOffset": 50525,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Guidelines for data collection, analysis and presentation of fetal growth restriction"
                }
            ],
            "secId": "s0120",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomized controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomized controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [70\u201372].",
            "startOffset": 50042,
            "title": "Data presentation"
        }
    ],
    "docId": "S0264410X17301032",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Sarah Rae",
                "initial": "S.R.",
                "last": "Easter"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Nansi",
                "initial": "N.",
                "last": "Boghossian"
            },
            {
                "email": null,
                "first": "Rebecca",
                "initial": "R.",
                "last": "Spencer"
            },
            {
                "email": null,
                "first": "Eugene",
                "initial": "E.",
                "last": "Oteng-Ntim"
            },
            {
                "email": null,
                "first": "Christos",
                "initial": "C.",
                "last": "Ioannou"
            },
            {
                "email": null,
                "first": "Manasi",
                "initial": "M.",
                "last": "Patwardhan"
            },
            {
                "email": null,
                "first": "Margo S.",
                "initial": "M.S.",
                "last": "Harrison"
            },
            {
                "email": null,
                "first": "Asma",
                "initial": "A.",
                "last": "Khalil"
            },
            {
                "email": null,
                "first": "Michael",
                "initial": "M.",
                "last": "Gravett"
            },
            {
                "email": null,
                "first": "Robert",
                "initial": "R.",
                "last": "Goldenberg"
            },
            {
                "email": null,
                "first": "Alastair",
                "initial": "A.",
                "last": "McKelvey"
            },
            {
                "email": null,
                "first": "Manish",
                "initial": "M.",
                "last": "Gupta"
            },
            {
                "email": null,
                "first": "Vitali",
                "initial": "V.",
                "last": "Pool"
            },
            {
                "email": null,
                "first": "Stephen C.",
                "initial": "S.C.",
                "last": "Robson"
            },
            {
                "email": null,
                "first": "Jyoti",
                "initial": "J.",
                "last": "Joshi"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Tom",
                "initial": "T.",
                "last": "McElrath"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.042",
        "firstpage": "6546",
        "issn": "0264410X",
        "lastpage": "6554",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data"
    }
}